| Health / Medical Topics |
Y 90 ibritumomab tiuxetan
Pronunciation
A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. Y 90 ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Y 90 ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called IDEC-Y2B8, Y 90 Zevalin, and yttrium Y 90 ibritumomab tiuxetan. (NCI Dictionary)
YOU MAY ALSO LIKE
A radioimmunoconjugate of monoclonal antibody against human carcinoembryonic antigen (CEA), labeled with yttrium 90 (Y-90). CEA is over-expressed in many tumor cell…
A rare syndrome affecting males. It is characterized by the presence of an extra Y chromosome. Individuals with this disorder are taller…
A form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better…
A pentose with a structure like glucose with a removed CH-OH group at carbon-5 (in Fisher projection).
The water-conducting tissue of plants, which makes up the wood cylinder of a tree, located inside the vascular cambium and surrounding the…
The normal genotype of a male human.
